Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 192

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

KrasG12D and p53 Mutation Cause Primary Intrahepatic Cholangiocarcinoma

Open access
O'Dell, Michael R., Li Huang, Jing, Whitney-Miller, Christa L., Deshpande, Vikram, Rothberg, Paul, Grose, Valerie, Rossi, Randall M., Zhu, Andrew X., Land, Hartmut, Bardeesy, Nabeel, Hezel, Aram F. · 2012 · Cancer Research

Abstract

Intrahepatic cholangiocarcinoma (IHCC) is a primary cancer of the liver with an increasing incidence and poor prognosis. Preclinical studies of the etiology and treatment of this disease are hampered by the relatively small number of available IHCC cell lines or genetically faithful animal models. Here we report the development of a genetically engineered mouse model of IHCC that incorporates two of the most common mutations in human IHCC, activating mutations of Kras (KrasG12D) and deletion of p53. Tissue-specific activation of KrasG12D alone resulted in the development of invasive IHCC with low penetrance and long latency. Latency was shortened by combining KrasG12D activation with heterozygous or homozygous deletion of p53 (mean survival of 56 weeks vs. 19 weeks, respectively), which also resulted in widespread local and distant metastasis. Serial analysis showed that the murine models closely recapitulated the multistage histopathologic progression of the human disease, including the development of stroma-rich tumors and the premalignant biliary lesions, intraductal papillary biliary neoplasms (IPBN), and Von Meyenburg complexes (VMC; also known as biliary hamartomas). These findings establish a new genetically and histopathologically faithful model of IHCC and lend experimental support to the hypothesis that IPBN and VMC are precursors to invasive cancers. Cancer Res; 72(6); 1557–67. ©2012 AACR.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-11-3596

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 192

Metadata

Authors
O'Dell, M. R., Li Huang, J., Whitney-Miller, C. L., Deshpande, V., Rothberg, P., Grose, V., Rossi, R. M., Zhu, A. X., Land, H., Bardeesy, N., & Hezel, A. F.
Venue
Cancer Research
Published
2012-03-14
Volume
72
Issue
6
Pages
1557-1567
ISSN
  • 0008-5472 (ISSN-L)
  • 1538-7445
OpenAlex
W2009550277
Cited by
192
References
5
FWCI
12.63
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: KrasG12D and p53 Mutation Cause Primary Intrahepatic Cholangiocarcinoma. https://app.cochat.ai/papers/10.1158/0008-5472.can-11-3596
The paper
O'Dell, M. R., Li Huang, J., Whitney-Miller, C. L., Deshpande, V., Rothberg, P., Grose, V., Rossi, R. M., Zhu, A. X., Land, H., Bardeesy, N., & Hezel, A. F. (2012). KrasG12D and p53 Mutation Cause Primary Intrahepatic Cholangiocarcinoma. Cancer Research. https://doi.org/10.1158/0008-5472.can-11-3596

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.